Neuland Laboratories Ltd

NSE: NEULANDLAB · BSE: 524558 · Pharmaceuticals & Biotechnology · 34 announcements

Share price: ₹21,905.00
Market cap: ₹28,104 Cr
Revenue (annual): ₹2,023 Cr
Net profit (annual): ₹364.0 Cr
P/E (TTM): 56.5×Sector 47.4×
Promoter holding: 32.62%-0.01% QoQ
FII holding: 21.08%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

5 Aug 2026 16:03 IST NSE

Neuland Laboratories Q1 FY27 Results: Net Profit ₹147.7 Cr, Up 962.6% YoY

Neuland Laboratories Ltd reported revenue from operations of ₹641.6 Cr (+119.1% YoY) and net profit of ₹147.7 Cr (+962.6% YoY) for Q1 FY27.

Key figure: Net profit ₹147.7 Cr · +962.6% YoY

Open full results → Read the filing ↗

12 May 2026 16:12 IST BSE

Financial ResultsAlfa Alert

Neuland Laboratories Q4 FY26 Results: Net Profit ₹212.7 Cr, Up 665.1% YoY

Neuland Laboratories Ltd reported revenue from operations of ₹776.3 Cr (+136.4% YoY) and net profit of ₹212.7 Cr (+665.1% YoY) for Q4 FY26.

Key figure: Net profit ₹212.7 Cr · +665.1% YoY

Open full results → Read the filing ↗

12 May 2026 16:11 IST BSE

Financial Results

Neuland Laboratories Financial Results

Neuland Laboratories reported annual financial results and recommended a ₹34 per share dividend. It also announced a ₹143.4 Crore capacity expansion at its Unit 1 facility.

Value: ₹143.4 Cr
Execution: 12 to 18 months

Read the filing ↗